Carla Madeira

ORCID: 0000-0002-4252-203X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Biomedical and Engineering Education
  • Diagnosis and treatment of tuberculosis
  • Clinical Laboratory Practices and Quality Control
  • Pneumonia and Respiratory Infections
  • Digital Imaging for Blood Diseases
  • Immunodeficiency and Autoimmune Disorders
  • Health and Medical Research Impacts
  • Antibiotic Resistance in Bacteria
  • Health Sciences Research and Education
  • Health Policy Implementation Science
  • Quality and Safety in Healthcare
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • SARS-CoV-2 detection and testing
  • Pneumocystis jirovecii pneumonia detection and treatment
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 epidemiological studies

Instituto Nacional de Saúde
2017-2024

Ministério da Saúde
2017

BackgroundChildhood tuberculosis remains a major cause of morbidity and mortality in part due to missed diagnosis. Diagnostic methods with enhanced sensitivity using easy-to-obtain specimens are needed. We aimed assess the diagnostic accuracy Cepheid Mycobacterium Host Response prototype cartridge (MTB-HR), candidate test measuring three-gene transcriptomic signature from fingerstick blood, children presumptive disease.MethodsRaPaed-TB was prospective study conducted at four sites African...

10.1016/s1473-3099(23)00491-7 article EN cc-by The Lancet Infectious Diseases 2023-10-30
Chad M. Centner Rahmawati Munir Elisa Tagliani Florian Rieß Philip Brown and 95 more Cindy Hayes Tania Dolby Widaad Zemanay Daniela María Cirillo Anura David Samuel G. Schumacher Claudia M. Denkinger Morten Rühwald Vinzeigh Leukes Mark P. Nicol Isak Van der Walt G Kisten Minkie Gumede A. Mace Adrian Brink Wendy Stevens Lesley Scott Adam Penn‐Nicholson Helen Cox Vinzeigh Leukes Adam Penn‐Nicholson Morten Rühwald Berra Erkoşar Samuel G. Schumacher Sunita Singh Bernard Kivuma Muhuminu Nuru Judith Mlenge Neema Shija Deogratias Bulime Dorcas Mnzava Petro Sabuni Hosiana Temba Jamali Siru Jerry Hella Jonathan Msafiri Maja Weisser Mohamed Mbaruku Mohamed Sasamalo A. S. Leonard Ambilikile Malango Annastazia Alexander Faith Komakoma Gloria Msigala Kasmir Johaness Grace Mhalu Mwajabu Hamis Priscilla Mlay Robert Ndege Sera Barasa Swalehe Masoud Theonestina Byakuzana Anange Lwilla Benedict Kayombo Chacha Mangu Christina Manyama Theodora Mbunda Elimina Siyame Issa Sabi Last Mwaipopo Nyanda Elias Ntinginya Raphael Edom Willyhelmina Olomi Délio Elísio Dinis Nguenha Edson Mambuque Joaquim Cossa Marta Cossa Neide Gomes Patricia Manjate Shilzia Munguambe Sozinho Acácio Belén Saavedra Hélio Chiconela Katia Ribeiro António Machiana Bindiya Meggi Cândido Azize Carla Madeira Celso Khosa Claudio Bila Denise Floripes Diosdélio Malamule Sofía Viegas Belén Saavedra Carole Amroune Joanna Ehrlich Lia Perez Sergi Sanz Alberto L. García‐Basteiro F. Rieß Sarah Mutuku Tejaswi Appalarowthu Lawrence O. Larson Katharina Kranzer

Abstract Background The World Health Organization–approved Xpert MTB/XDR test detects Mycobacterium tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, injectable drugs directly in specimens. This pragmatic, laboratory-based study assessed the diagnostic accuracy feasibility of a reflex testing approach, where was performed on residual specimens previously processed for MTB/RIF Ultra. Methods Routine respiratory specimens, Ultra, were stored sample reagent buffer at...

10.1093/ofid/ofae437 article EN cc-by Open Forum Infectious Diseases 2024-07-30
Chacha Mangu Marta Cossa Robert Ndege Celso Khosa Vinzeigh Leukes and 95 more Laura de la Torre‐Pérez António Machiana Bernard Kivuma Dorcas Mnzava Craysophy Zachariah Patricia Manjate Elisa Tagliani Claudia Schacht J. Buech Sunita Singh Joanna Ehrlich F. Rieß Sergi Sanz Katharina Kranzer Helen Cox Issa Sabi Dinis Nguenha Bindiya Meggi Maja Weisser Nyanda Elias Ntinginya Samuel G. Schumacher Morten Rühwald Adam Penn‐Nicholson Alberto L. García‐Basteiro Berra Erkoşar Muhuminu Nuru Mahmud Mahmud Neema Shija Deogratias Bulime Petro Sabuni Hosiana Temba Jamali Siru Jerry Hella Jonathan Msafiri Mohamed Mbaruku Mohamed Sasamalo A. S. Leonard Ambilikile Malango Annastazia Alexander Faith Komakoma Gloria Msigala Kasmir Johaness Grace Mhalu Mwajabu Hamis Priscilla Mlay Sera Barasa Swalehe Masoud Theonestina Byakuzana Anange Lwilla Pauline Sylvester Emanuel Sichone Subira Wailes Bariki Mtafya Abisai Kisinda M Martine Regino Mgaya Christina Manyama Theodora Mbunda Elimina Siyame Last Mwaipopo Nyanda Elias Ntinginya Raphael Edom Willyhelmina Olomi Délio Elísio Edson Mambuque Joaquim Cossa Neide Gomes Shilzia Munguambe Sozinho Acácio Hélio Chiconela Katia Ribeiro Carla Madeira Daniel Machavae Emelva Manhiça Onélia Guiliche Diosdélio Malamule Sofía Viegas Belén Saavedra Carlos Fernández‐Escobar Michael Hoelscher Norbert Heinrich Leyla Larsson María del Mar Castro Claudia M. Denkinger Saima Arif Daniela María Cirillo Federico Di Marco Virginia Batignani Akash Malhotra David W. Dowdy Caroline Stöhr Marguerite Massinga Loembé Pascale Ondoa Nqobile Ndlovu Fumbani Brown

Tuberculosis (TB) is an important cause of morbidity and mortality among people living with HIV (PLHIV). Current WHO-recommended strategies for diagnosing TB hospitalized PLHIV rely on symptom screening disease severity to assess eligibility urine lipoarabinomannan lateral flow (LF-LAM) molecular testing. Despite these recommendations, autopsy studies show a large burden undiagnosed admitted PLHIV. The EXULTANT trial aims the impact expanded strategy using three specimens (sputum, stool,...

10.1186/s12879-024-09651-z article EN cc-by-nc-nd BMC Infectious Diseases 2024-08-15

Tuberculosis (TB) diagnostics are centralised, requiring long-distance transportation of specimens in most resource-limited settings. We evaluated the ability OMNIgene.SPUTUM (OM-S) to obviate cold-chain transport TB specimens. A two-arm (same-day and after 5 days sample processing) study was conducted assess contamination rates Mycobacterium tuberculosis viability OM-S-treated samples against standard decontamination procedure (SDP) Mozambique, using Lowenstein Jensen (LJ) mycobacterial...

10.1183/23120541.00074-2017 article EN cc-by-nc ERJ Open Research 2018-01-01

Internationally-accredited laboratories are recognised for their superior test reliability, operational performance, quality management and competence. In a bid to meet international standards, the Mozambique National Institute of Health enrolled Tuberculosis Reference Laboratory (NTRL) in continuous improvement process towards ISO 15189 accreditation. Here, we describe road map taken by NTRL achieve accreditation.The adopted Strengthening Management Toward Accreditation (SLMTA) programme as...

10.4102/ajlm.v6i2.491 article EN cc-by African Journal of Laboratory Medicine 2017-03-31

Mozambique is among the highest tuberculosis, tuberculosis-HIV and multidrug-resistant-tuberculosis burden countries. Although molecular technologies are available in-country, mycobacterial isolation through culture remains an important tool for tuberculosis diagnostics drug susceptibility testing.We evaluated use of Ogawa-Kudoh (OK) culture, a simple technique, to isolate Mycobacterium in two health units, Maputo City, Mozambique.From May December 2014, 122 patient samples were collected...

10.4102/ajlm.v9i1.929 article EN cc-by African Journal of Laboratory Medicine 2020-07-18

Abstract Background In 2020, the WHO-approved Molbio Truenat platform and MTB assays to detect Mycobacterium tuberculosis complex (MTB) resistance rifampicin directly on sputum specimens. This primary health care center-based trial in Mozambique Tanzania investigates effect of platform/MTB (intervention arm) combined with rapid communication results compared standard TB diagnosis treatment initiation for microbiologically confirmed at 7 days from enrolment. Methods The Tuberculosis Close...

10.21203/rs.3.rs-3348643/v1 preprint EN cc-by-nc-sa Research Square (Research Square) 2023-10-03

There are many challenges that impact the current referral network for Tuberculosis (TB) sputum specimens in Mozambique. In some cases, health facilities remote and road infrastructure is poor at times impassable, leading to delays laboratory specimen transportation long turn-around results. Drone a promising solution reduce time improve access diagnostics if sample quality not compromised during transport. This study evaluated of drone on TB with suspected Mycobacterium tuberculosis. 156...

10.3390/drones6070155 article EN cc-by Drones 2022-06-23
Coming Soon ...